Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 309, Issue 3, pp 259–269 | Cite as

Properties of the muscarinic cholinergic receptors in rat atrium

  • Jiann-Wu Wei
  • Prakash V. Sulakhe
Article
Received:
Accepted:

Summary

1. Properties of the muscarinic cholinergic receptor sites in the rat atrial homogenate and microsomal fraction were studied by the use of tritium labelled 3′-quinuclidinyl benzilate ([3H]-QNB), a potent muscarinic antagonist. 2. The specific [3H]-QNB binding to the receptor sites displayed saturability, stereospecificity as well as reversibility. 3. The competition studies showed that muscarinic antagonists were more potent than muscarinic agonists. 4. Certain neuromuscular blocking agents, antipsychotics, antiarrhythmics and antihistamines also were capable of interacting with the [3H]-QNB binding sites. However, α- and β-adrenergic agents, calcium antagonist (D-600) and ionophore (A-23187) failed to show any effect. 5. Analyses by the double reciprocal plot, Hill plot and Scatchard plot of the dependence of the specific [3H]-QNB binding on the concentration of QNB suggested that binding was occurring to a single population of receptor sites in the atrial homogenate or microsomal fraction. Further, there was no evidence of any detectable site to site interactions (positive or negative cooperative type). From the Scatchard plot, the equilibrium dissociation constant (KD) of 1.1 nM was calculated and the Hill coefficient was close to 1.0 6. Interaction of the muscarinic antagonists with the [3H]-QNB sites showed the Hill coefficients close to 1.0 whereas for the agonists, the coefficients were much less than 1.0 indicating that agonist-receptor site interactions have some different characteristics from those following antagonist-receptor site interaction. 7. The rate and the maximal level of QNB binding to the receptor sites was markedly influenced by the temperature; various cations, on the other hand, displayed no effect either on the association or dissociation of QNB binding. The specific QNB binding exhibited a broad pH optimum from pH 6.0–8.5. 8. Treatment of the membrane fraction (or homogenate) with either phospholipase A or C and with p-chloromercuribenzoate caused significant inhibition of [3H]-QNB binding. 9. The QNB binding site was resistant to tryptic digestion. Even when about 40% of the membrane proteins were removed by the tryptic proteolysis, the [3H]-QNB binding ability of the membrane remained unaffected; in fact, the removal of tryptic proteolytic products by centrifugation markedly increased the specific QNB binding to the membrane.

Key words

Rat heart atria Muscarinic receptors Cholinergic agonists and antagonists Cations Phospholipases Microsomal fraction 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aronstam, R. S., Abood, L. G., Baumgold, J.: Role of phospholipids in muscarinic binding by neural membranes. Biochem. Pharmacol. 26, 1689–1695 (1977)Google Scholar
  2. Aronstam, R. S., Abood, L. C., Hass, W.: Influence of sulfhydryl reagents and heavy metals on the functional state of the muscarinic acetylcholine receptor in rat brain. Mol. Pharmacol. 14, 575–586 (1978)Google Scholar
  3. Beld, A. J., Ariëns, E. J.: Stereospecific binding as a tool in attempts to localize and isolate muscarinic receptors. Part II. Binding of (±)-benzetimide, (−)-benzetimide and atropine to a fraction from bovine tracheal smooth muscle and to bovine caudate nucleus. Eur. J. Pharmacol. 25, 203–209 (1974)Google Scholar
  4. Birdsall, N. J. M., Hulme, E. C.: Biochemical studies on muscarinic acetylcholine receptors. J. Neurochem. 27, 7–16 (1976)Google Scholar
  5. Birdsall, N. J. M., Burgen, A. S. V., Hulme, E. C.: The binding of agonists to brain muscarinic receptors. Mol. Pharmacol. 14, 723–736 (1978)Google Scholar
  6. Brown, O. M.: Cat heart acetylcholine: Structural proof and distribution. Am. J. Physiol. 231, 781–785 (1976)Google Scholar
  7. Cavey, D., Vincent, J. P., Lazdunski, M.: The muscarinic receptor of heart cell membranes: Association with agonists, antagonists and antiarrhythmic agents. FEBS Lett. 84, 110–114 (1977)Google Scholar
  8. De Meyts, P.: Cooperative properties of hormone receptors in cell membranes. J. Supramol. Struct. 4, 241–258 (1976)Google Scholar
  9. De Meyts, P., Roth, J., Neville, D. M., Jr., Gavin, J. R., III, Lesniak, M. A.: Insulin interactions with its receptors: Experimental evidence for negative cooperativity. Biochem. Biophys. Res. Commun. 55, 154–161 (1973)Google Scholar
  10. Eldefrawi, M. E., Eldefrawi, A. T.: Characterization and partial purification of the acetylcholine receptor from Torpedo electroplax. Proc. Natl. Acad. Sci. USA 69, 1776–1780 (1972)Google Scholar
  11. Fields, J. Z., Roeske, W. R., Morkin, E., Yamamura, H. I.: Cardiac muscarinic cholinergic receptors: Biochemical identification and characterization. J. Biol. Chem. 253, 3251–3258 (1978)Google Scholar
  12. Fleisch, J. H., Krzan, M. C., Titus, W.: Alterations in pharmacologic receptor activity by dithiothreitol. Am. J. Physiol. 227, 1243–1248 (1974)Google Scholar
  13. Galper, J. B., Smith, T. W.: Properties of muscarinic acetylcholine receptors in heart cell cultures. Proc. Natl. Acad. Sci. USA 75, 5831–5835 (1978)Google Scholar
  14. Galper, J. B., Klein, W., Catterall, W. A.: Muscarinic acetylcholine receptors in developing chick heart. J. Biol. Chem. 252, 8692–8699 (1977)Google Scholar
  15. Gray, J. A., Lüllmann, H., Mitchelson, F., Reil, G.-H.: Stereoselective binding in cardiac tissue of the enantiomers of benzetimide, an antimuscarinic drug. Br. J. Pharmacol 56, 485–490 (1976)Google Scholar
  16. Heilbronn, E., Bartfai, T.: Muscarinic acetylcholine receptor. Prog. Neurobiol. 11, 171–188 (1978)Google Scholar
  17. Higgins, C. B., Vatner, S. F., Braunwald, E.: Parasympathetic control of the heart. Pharmacol. Rev. 25, 119–155 (1973)Google Scholar
  18. Hill, A. V.: The mode of action of nicotine and curare, determined by the form of the contraction curve and the method of temperature coefficients. J. Physiol. (Lond.) 39, 361–373 (1909)Google Scholar
  19. Hughes, R., Chapple, D. J.: Cardiovascular and neuromuscular effects of dimethyl tubocurarine in anaesthetized cats and rhesus monkeys. Brit. J. Anaesth. 48, 847–852 (1976)Google Scholar
  20. Hurko, O.: Specific [3H]quinuclidinyl benzilate binding activity in digitonin-solubilized preparations from bovine brain. Arch. Biochem. Biophys. 190, 434–445 (1978)Google Scholar
  21. Janssen, P. A. J., Niemegeers, C. J. E., Schellekens, K. H. L., Demoen, P., Lenaerts, F. M., Van Neuten, J. M., Van Wijngaarden, I., Brugmans, J. Benzetimide and its optical isomers. Arzneim. Forsch. 21, 1365–1373 (1971)Google Scholar
  22. Kloog, Y., Sokolovsky, M.: Muscarinic acetylcholine receptors interactions: Competition binding studies with agonists and antagonist. Brain Res. 134, 167–172 (1977)Google Scholar
  23. Lefkowitz, R. J., Limbird, L. E., Mukherjee, C., Caron, M. G.: The β-adrenergic receptor and adenylate cyclase. Biochim. Biophys. Acta 457, 1–39 (1976)Google Scholar
  24. Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J.: Protein measurements with the Folin phenol reagent. J. Biol. Chem. 193, 265–275 (1951)Google Scholar
  25. Lüllmann, H., Ziegler, A.: A transient state concept of drug receptor interaction. Naunyn-Schmiedeberg's Arch. Pharmacol. 280, 1–21 (1973)Google Scholar
  26. Ma, S. K., Sulakhe, P. V., Leung, N. L. K.: Binding of [3H]atropine by cardiac plasma membrane-enriched fractions. In: Recent advances in studies on cardiac structure and metabolism (T. Kobayashi, T. Sano, N. S. Dhalla, eds.), 11, 249–265. Baltimore: University Park Press 1978Google Scholar
  27. Moe, G. K., Abildskov, J. A.: Antiarrhythmic drugs. In: The pharmacological basis of therapeutics (L. S. Goodman, A. Gilman, eds.), 5, 683–704. New York: MacMillan 1975Google Scholar
  28. Narayanan, N., Sulakhe, P. V.: 5′-Guanylylimidodiphosphate-activated adenylate cyclase of cardiac sarcolemma displays higher affinity for magnesium ions. Mol. Pharmacol. 13, 1033–1047 (1977)Google Scholar
  29. Scatchard, G.: The attractions of proteins for small molecules and ions. Ann. N. Y. Acad. Sci. 51, 660–672 (1949)Google Scholar
  30. Sharma, V. K., Banerjee, S. P.: Muscarinic cholinergic receptors in rat heart: Effects of thyroidectomy. J. Biol. Chem. 252, 7444–7446 (1977)Google Scholar
  31. Snyder, S. H., Chang, K. J., Kuhar, M. J., Yamamura, H. I.: Biochemical identification of the mammalian muscarinic cholinergic receptor. Fed. Proc. 34, 1915–1921 (1975)Google Scholar
  32. Soudijn, W., Van Wijngaarden, I., Ariëns, E. J.: Dexetimide, a useful tool in acetylcholine receptor localization. Eur. J. Pharmacol. 24, 43–48 (1973)Google Scholar
  33. St. Louis, P. J., Sulakhe, P. V.: Protein analysis of cardiac sarcolemma: Effects of membrane-perturbing agents on membrane proteins and calcium transport. Biochemistry 17, 4540–4550 (1978)Google Scholar
  34. Stubbins, J. F., Hudgins, P. M.: Sulfhydryl group reagents: Effect on intestinal smooth muscle. Experientia 27, 669–670 (1971)Google Scholar
  35. Sulakhe, P. V., Dhalla, N. S.: Adenylate cyclase of heart sarcotubular membranes. Biochim. Biophys. Acta 293, 379–396 (1973)Google Scholar
  36. Wei, J.-W., Sulakhe, P. V.: Regional and subcellular distribution of myocardial muscarinic cholinergic receptors. Eur. J. Pharmacol. 52, 235–238 (1958)Google Scholar
  37. Wei, J.-W., Narayanan, N., Sulakhe, P. V.: Characterization of a β-adrenoceptor-coupled adenylate cyclase system of sarcolemma. Proc. Can. Fed. Biol. Soc. 20, 176 (abstract) (1977)Google Scholar
  38. Yamamura, H. I., Snyder, S. H.: Muscarinic cholinergic binding in rat brain. Proc. Natl. Acad. Sci. USA 71, 1725–1729 (1974a)Google Scholar
  39. Yamamura, H. I., Snyder, S. H.: Muscarinic cholinergic receptor binding in the longitudinal muscle of the guinea pig ileum with [3H]quinuclidinyl benzilate. Mol. Pharmacol. 10, 861–867 (1974b)Google Scholar
  40. Young, J. M.: Desensitisation and agonist binding to cholinergic receptors in intestinal smooth muscle. FEBS Lett. 46, 354–356 (1974)Google Scholar

Copyright information

© Springer-Verlag 1979

Authors and Affiliations

  • Jiann-Wu Wei
    • 1
  • Prakash V. Sulakhe
    • 1
  1. 1.Department of Physiology, College of MedicineUniversity of SaskatchewanSaskatoonCanada

Personalised recommendations